Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms, Plasma Cell 1Neoplasms 1Influenza, Human 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Fluzone High-Dose × Clear all
NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Emory University

Phase 4 Completed
165 enrolled 9 charts
Plasma cell

Neoplasms, Plasma Cell

NCT01666782 2016-06-24

IMMUNE

Rochester General Hospital

Phase 2 Completed
105 enrolled 10 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡